Type 2 Diabetes and ADP Receptor Blocker Therapy

Type 2 diabetes (T2D) is associated with several abnormalities in haemostasis predisposing to thrombosis. Moreover, T2D was recently connected with a failure in antiplatelet response to clopidogrel, the most commonly used ADP receptor blocker in clinical practice. Clopidogrel high on-treatment plate...

Full description

Saved in:
Bibliographic Details
Published in:J Diabetes Res
Main Authors: Samoš, Matej, Fedor, Marián, Kovář, František, Mokáň, Michal, Bolek, Tomáš, Galajda, Peter, Kubisz, Peter, Mokáň, Marián
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2016
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4707344/
https://ncbi.nlm.nih.gov/pubmed/26824047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6760710
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items